Operative Management of Scapular Fractures

Sponsor
Assiut University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05982327
Collaborator
(none)
20
18.4

Study Details

Study Description

Brief Summary

Assessment of functional outcome of operative management of scapular fractures through Arabic version DASH score

Condition or Disease Intervention/Treatment Phase
  • Procedure: ORIF

Detailed Description

Scapular fractures are rare, accounting less than1% all fractures. 3-5%all fractures of shoulder girdle, however very serious because 80-90% due to high energy trauma such as Motor car accidents or Fall from height. It can be associated with life-threatening injuries such as thoraco-scapular dissociation and vascular injury as subclavian and axillary vessels and brachial plexus injuries.So morbidity and mortality reports are relatively high.It can be diagnosed by X ray and computed tomography scan (CT scan) that play important role to discover scapular fractures and associated injuries ,and to guide clinical decision such as approaches and other surgical interventions.Most of scapular fractures are managed conservatively by Immbolization in sling .literature stated that conservative management of scapular body fractures and scapular neck fractures displaced less than 10 mm have satisfactory outcome and operative management suitable for displaced glenoid fossa fractures and scapular neck fractures more than 10 mm and associated with better functional outcome.Others stated that conservative management with highly displaced scapular body and neck fractures are associated with satisfactory long -term functional outcome with minor loss of motion and strength.

So standard treatment of scapular fracture is still controversial and there is no clear guidelines about management of scapular fractures.

In Investigators hypothesis, Operative management of scapular fractures is better choice due to better functional outcome, early rehabilitation ,high union rate and less complications. Investigators will try to answer this question ''What is the effect of operative management of scapular fractures on functional outcome?''

Study Design

Study Type:
Observational
Anticipated Enrollment :
20 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
Assessment of Operative Management of Scapular Fractures in Level 1 Trauma Center
Anticipated Study Start Date :
Aug 20, 2023
Anticipated Primary Completion Date :
Jan 1, 2025
Anticipated Study Completion Date :
Mar 1, 2025

Outcome Measures

Primary Outcome Measures

  1. Assessment of functional outcome [6 week]

    Arabic version DASH score

Secondary Outcome Measures

  1. Range of motion [Six months]

    Goniometer

  2. Strength of shoulder muscle [Six months]

    Handheld dynamometer

  3. Union rate [Six months]

    X ray-CT

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Inclusion Criteria:
  • 1.All patient presented with scapular fractures more than 18 years old involving body, neck and glenoid 2.Intraarticular glenoid fractures with step-off >4 mm 3.>20% of the joint is involved and Fragment large enough to be hold by lag screw.
Exclusion Criteria:

1- Low demanded patients:Age >65 yrs . 2.Scapular fractures of acromion and coracoid process and Osteoporotic fractures .

3.Scapular fractures associated with brain injuries cervical spine injuries and brachial plexus injuries.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Assiut University

Investigators

  • Principal Investigator: Ahmed Elbadry Mahmoud, Resident, Assiut University
  • Study Director: Aly Mohamadean, Prof Dr, Assiut University
  • Study Director: Mahmoud Badran, Ass.prof, Assiut University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ahmed Elbadry Mahmoud Ahmed, Assuit lecturer, Assiut University
ClinicalTrials.gov Identifier:
NCT05982327
Other Study ID Numbers:
  • Scapular fractures
First Posted:
Aug 8, 2023
Last Update Posted:
Aug 8, 2023
Last Verified:
Aug 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 8, 2023